These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3099900)

  • 1. Blood cyclosporin concentrations and renal allograft dysfunction.
    Lui SF; Varghese Z; Sweny P; Fernando ON; Moorhead JF
    Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1435. PubMed ID: 3099900
    [No Abstract]   [Full Text] [Related]  

  • 2. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients.
    Taube DH; Neild GH; Williams DG; Cameron JS; Hartley B; Ogg CS; Rudge CJ; Welsh KI
    Lancet; 1985 Jul; 2(8448):171-4. PubMed ID: 2862369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood cyclosporin concentrations and renal allograft dysfunction.
    Holt DW; Marsden JT; Johnston A; Bewick M; Taube DH
    Br Med J (Clin Res Ed); 1986 Oct; 293(6554):1057-9. PubMed ID: 3094774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convulsions associated with cyclosporin A in renal transplant recipients.
    Beaman M; Parvin S; Veitch PS; Walls J
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):139-40. PubMed ID: 3917716
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cyclosporin in kidney transplantation].
    Land W; Castro LA; Hillebrand G; Klare B; Illner WD; Fornara P
    Internist (Berl); 1985 Sep; 26(9):549-52. PubMed ID: 3905675
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
    Ubhi CS; Woodhouse L; Guillou PJ; Giles GR
    Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some experimental and clinical studies of Cyclosporin A in renal transplantation.
    Morris PJ
    Transplant Proc; 1982 Sep; 14(3):525-8. PubMed ID: 6758238
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin A tissue levels in a cadaveric renal allograft recipient.
    Kahan BD; Van Buren CT; Boileau M; Ried M; Payne WD; Flechner S; Newburger J
    Transplantation; 1983 Jan; 35(1):96-9. PubMed ID: 6337438
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of cyclosporin A on the situ inflammatory response of human renal allograft rejection. A preliminary report.
    Häyry P; Ahonen J; von Willebrand E; Eklund B; Höckekstedt K; Kauste A; Taskinen E; Lautenschlager I; Lalla M; Sarelin H
    Scand J Immunol; 1982 Aug; 16(2):135-49. PubMed ID: 6753125
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experience with the monitored cyclosporin A treatment of kidney transplant patients].
    Beleva B; Kurtev I; Stefanov G
    Khirurgiia (Sofiia); 1987; 40(3):66-70. PubMed ID: 3306122
    [No Abstract]   [Full Text] [Related]  

  • 11. [The diagnosis of cyclosporin nephrotoxicity in patients after kidney transplantation].
    Rozental' RL; Il'inskiĭ IM; Bitsans IaB; Strokan' VA
    Ter Arkh; 1990; 62(6):92-4. PubMed ID: 2218937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin conversion in renal transplantation.
    Paul LC; Henny FC; Lensen LM; Kootte AM; van Bockel H
    Lancet; 1987 Apr; 1(8538):917. PubMed ID: 2882312
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporin A in cadaveric renal transplantation.
    D'Apice AJ
    Med J Aust; 1985 Feb; 142(3):172-4. PubMed ID: 3881653
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporin nephrotoxicity.
    Neild GH
    Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):198-203. PubMed ID: 2081228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of early cyclosporine dosage and plasma and whole blood levels on acute rejections in cadaveric renal allograft recipients.
    Lindholm A; Lundgren G; Fehrman I; Weibull H; Brynger H; Frödin L; Flatmark A
    Transplant Proc; 1988 Jun; 20(3):444-6. PubMed ID: 3289181
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporin in renal transplantation: a guide to management.
    Salaman JR
    Lancet; 1984 Aug; 2(8397):269-71. PubMed ID: 6146819
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporin A efficacy and toxicity in organ transplantation with special focus on cadaveric renal transplantation.
    Lesne M; Squifflet JP; Wallemacq P; Lenain F; Alexandre G
    Chemioterapia; 1985 Oct; 4(5):400-5. PubMed ID: 3907864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing between renal allograft rejection and cyclosporin nephrotoxicity.
    Hrushesky WJ
    Lancet; 1985 Aug; 2(8453):501. PubMed ID: 2863520
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the clinical, histopathologic, cytologic, and biochemical features of renal transplant rejection, cyclosporine A nephrotoxicity, and stable renal function.
    Taube D; Neild G; Hobby P; Holt D; Welsh K; Cameron JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):179-84. PubMed ID: 3895658
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection.
    Veremis SA; Maddux MS; Tang IY; Millner SN; Prasad R; Pollak R; Mozes MF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1476-7. PubMed ID: 2652473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.